Prestige Wealth Management Group’s Genmab GMAB Stock Holding History

Prestige Wealth Management Group’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-64	Closed	-$1.34K	–	1030
2024 Q4	$1.34K	Hold	64	–	–	﹤0.01%	842
2024 Q3	$1.56K	Hold	64	–	–	﹤0.01%	821
2024 Q2	$1.61K	Hold	64	–	–	﹤0.01%	764
2024 Q1	$1.92K	Hold	64	–	–	﹤0.01%	755
2023 Q4	$2.04K	Hold	64	–	–	﹤0.01%	735
2023 Q3	$2.26K	Hold	64	–	–	﹤0.01%	710
2023 Q2	$2.43K	Hold	64	–	–	﹤0.01%	727
2023 Q1	$2.42K	Hold	64	–	–	﹤0.01%	713
2022 Q4	$2.71K	Hold	64	–	–	﹤0.01%	768
2022 Q3	$2K	Hold	64	–	–	﹤0.01%	733
2022 Q2	$2K	Hold	64	–	–	﹤0.01%	747
2022 Q1	$2K	Sell	64 -85	-57%	-$2.92K	﹤0.01%	768
2021 Q4	$6K	Buy	149 +2	+1%	+$83	﹤0.01%	586
2021 Q3	$6K	Sell	147 -29	-16%	-$1.3K	﹤0.01%	592
2021 Q2	$7K	Hold	176	–	–	﹤0.01%	556
2021 Q1	$6K	Buy	176 +32	+22%	+$1.2K	﹤0.01%	579
2020 Q4	$6K	Buy	144 +80	+125%	+$2.99K	﹤0.01%	537
2020 Q3	$2K	Hold	64	–	–	﹤0.01%	676
2020 Q2	$2K	Sell	64 -39	-38%	-$1.06K	﹤0.01%	667
2020 Q1	$2K	Buy	103 +89	+636%	+$1.98K	﹤0.01%	635
2019 Q4	$0	Hold	14	–	–	﹤0.01%	618
2019 Q3	$0	Buy	+14	New	+$276	﹤0.01%	611

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Prestige Wealth Management Group's GMAB Position: Q1 2025 in Review

Prestige Wealth Management Group sold out of Genmab (GMAB) in Q1 2025, closing a stake of 64 shares — an estimated $1.34K sold.

Prestige Wealth Management Group first reported a position in GMAB in Q3 2019 and held it in 22 quarters. The position peaked at $7K in Q2 2021. 219 funds tracked by Wall St. Rank hold GMAB as of Q1 2025.

Prestige Wealth Management Group reported no remaining Genmab position as of Q1 2025 after selling out during the quarter.
Prestige Wealth Management Group sold 64 Genmab shares in Q1 2025, an estimated $1.34K.
Prestige Wealth Management Group first reported a position in Genmab in Q3 2019 and held it in 22 quarters.
Prestige Wealth Management Group's Genmab position peaked at $7K in Q2 2021.
219 funds tracked by Wall St. Rank held Genmab as of Q1 2025.

Based on Prestige Wealth Management Group's 13F filing for Q1 2025, filed 12 May 2025.